DTL
ACAD icon

Dynamic Technology Lab’s Acadia Pharmaceuticals ACAD Stock Holding History

Dynamic Technology Lab’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,229
Closed -$342K – 865
2024
Q3 		$342K Buy
+22,229
New +$371K 0.04% 685
2024
Q1 		– Sell
-18,870
Closed -$591K – 1006
2023
Q4 		$591K Buy
18,870
+5,997
+47% +$143K 0.06% 525
2023
Q3 		$268K Buy
+12,873
New +$350K 0.03% 702
2023
Q2 		– Sell
-39,075
Closed -$736K – 946
2023
Q1 		$736K Buy
+39,075
New +$744K 0.07% 494
2022
Q4 		– Sell
-21,618
Closed -$354K – 1045
2022
Q3 		$354K Buy
+21,618
New +$350K 0.03% 749
2022
Q2 		– Sell
-40,490
Closed -$981K – 1065
2022
Q1 		$981K Buy
+40,490
New +$980K 0.12% 283
2021
Q3 		– Sell
-8,540
Closed -$208K – 1016
2021
Q2 		$208K Buy
+8,540
New +$193K 0.02% 926
2020
Q3 		– Sell
-7,137
Closed -$346K – 943
2020
Q2 		$346K Buy
+7,137
New +$343K 0.05% 620
2020
Q1 		– Sell
-7,465
Closed -$319K – 976
2019
Q4 		$319K Sell
7,465
-3,622
-33% -$158K 0.05% 644
2019
Q3 		$399K Buy
11,087
+3,420
+45% +$104K 0.07% 525
2019
Q2 		$205K Buy
+7,667
New +$196K 0.03% 803
2019
Q1 		– Sell
-17,815
Closed -$288K – 937
2018
Q4 		$288K Buy
+17,815
New +$346K 0.05% 649

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Dynamic Technology Lab's ACAD Position: Q4 2024 in Review

Dynamic Technology Lab sold out of Acadia Pharmaceuticals (ACAD) in Q4 2024, closing a stake of 22,229 shares — an estimated $342K sold.

Dynamic Technology Lab first reported a position in ACAD in Q4 2018 and held it in 12 quarters. The position peaked at $981K in Q1 2022. 296 funds tracked by Wall St. Rank hold ACAD as of Q4 2024.

  • Dynamic Technology Lab reported no remaining Acadia Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 22,229 Acadia Pharmaceuticals shares in Q4 2024, an estimated $342K.
  • Dynamic Technology Lab first reported a position in Acadia Pharmaceuticals in Q4 2018 and held it in 12 quarters.
  • Dynamic Technology Lab's Acadia Pharmaceuticals position peaked at $981K in Q1 2022.
  • 296 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2024.

Based on Dynamic Technology Lab's 13F filing for Q4 2024, filed 13 Feb 2025.